Pre-Open Stock Movers 10/13: (WTRH) (KOSS) (RVNC) Higher; (RGLS) (ARDX) (STIM) Lower (more...)

October 13, 2021 9:24 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Pre-Open Stock Movers:

Waitr Holdings (NASDAQ: WTRH) 38.5% HIGHER; Morgan Stanley files 13G

Regulus Therapeutics Inc. (Nasdaq: RGLS) 29.6% LOWER; announced the prioritization of its promising, next-generation candidate, RGLS8429, for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The Company recently completed the dosing period of the in-life portion of the IND-enabling toxicity studies for RGLS8429; anticipates submitting an Investigational New Drug application (IND); and subject to U.S. Food and Drug Administration (FDA) clearance, initiating a phase 1 study in the second quarter of 2022.

Ardelyx, Inc. (Nasdaq: ARDX) 22% LOWER; announced that the company has met with the U.S. Food and Drug Administration (FDA) in a Type A meeting, but was not provided sufficient clarity on what constitutes "clinical relevance of the magnitude of treatment effect" and continues to await additional information regarding the path forward for the company's New Drug Application (NDA) for tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis.

Neuronetics, Inc. (NASDAQ: STIM) 19.8% LOWER; provided preliminary revenue results for the third quarter of 2021. The Company expects total revenue for the third quarter to be approximately $13.8 million, compared to previously issued guidance of $15.0 million to $16.0 million. The Company now expects full-year revenue to be in the range of $53.3 million to $54.3 million.

Koss Corp (NASDAQ: KOSS) 12.3% HIGHER; Adds to Tuesday gains after it prevails in Apple IPR patent challenge to Koss '982 wireless earphones patent as the PTAB denied institution of the patent trial.

Revance Therapeutics, Inc. (Nasdaq: RVNC) 11% HIGHER; responds to the public disclosure of its Form 483 pursuant to a Freedom of Information Act (FOIA) request that was directed to the FDA. The Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection remains under FDA review and the company continues to anticipate FDA approval of DaxibotulinumtoxinA for Injection for the treatment of glabellar lines in 2021.

Rezolute, Inc. (Nasdaq: RZLT) 11% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering, and, in lieu of common stock, Rezolute intends to offer and sell to certain investors pre-funded warrants to purchase shares of its common stock.

Jasper Therapeutics (NASDAQ: JSPR) 7.6% HIGHER; Oppenheimer initiates coverage with an Outperform rating and $21 price target.

Plug Power (NASDAQ: PLUG) 6.6% HIGHER; Morgan Stanley upgraded from Equalweight to Overweight with a price target of $40.00 (from $35.00).

Vistra Corp. (NYSE: VST) 6.5% HIGHER; announced a new $2 billion share repurchase program and the pricing of a private offering of 1,000,000 shares of its 8% Series A Fixed-Rate Reset Cumulative Redeemable Perpetual Preferred Stock to qualified institutional buyers.

DatChat (NASDAQ: DATS) 6.3% HIGHER; through its media partner, SJD Media & Marketing, entered into an agreement (the “Agreement”) with Barstool Sports, (“Barstool”), a digital media company that produces content focused on sports and pop-culture, to launch a multi-channel, national marketing campaign for DatChat Messenger across the Barstool Sports brand and select franchises for an agreed upon period of time in consideration of the Company paying Barstool a low seven figure fee.

Sarepta Therapeutics, Inc. (Nasdaq: SRPT) 6% LOWER; announced that it is offering to sell, subject to market and other conditions, $500,000,000 in shares of its common stock in an underwritten public offering. Sarepta also intends to grant the underwriters a 30-day option to purchase up to an additional $75,000,000 in shares of its common stock.

Sarcos Technology and Robotics (NASDAQ: STRC) 5.9% HIGHER; Jefferies initiates coverage with a Buy rating and a price target of $16.00.

The Duckhorn Portfolio, Inc. (NYSE: NAPA) 5.2% LOWER; announced the commencement of an underwritten public offering of 12,000,000 shares of its common stock by certain of its stockholders.

Apollo Endosurgery, Inc. (NASDAQ: APEN) 4.3% LOWER; intends to offer and sell shares of its common stock in an underwritten public offering. All of the common stock is being offered by Apollo. In addition, Apollo expects to grant the underwriters a 30-day option to purchase additional shares of common stock.

Paycor HCM, Inc. (NASDAQ: PYCR) 3.4% LOWER; announced the commencement of a public offering of its common stock by certain selling stockholders (the Offering). The selling stockholders are offering 12,000,000 shares of Paycors common stock pursuant to a registration statement on Form S-1 (the Registration Statement) filed with the Securities and Exchange Commission (the SEC).

Ellington Financial Inc. (NYSE: EFC) 3.1% LOWER; announced today that it has commenced an underwritten public offering of 5,000,000 shares of common stock. The Company also expects to grant the underwriters an option for 30 days to purchase up to an additional 750,000 shares of common stock. Morgan Stanley & Co. LLC, BofA Securities, J.P. Morgan, UBS Securities LLC and Keefe, Bruyette & Woods, A Stifel Company are acting as joint book-running managers for the offering.

Skyworks Solutions, Inc. (NASDAQ: SWKS) 2% LOWER; Apple product cuts due to chip shortages.

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) 2% LOWER; announced today that it has commenced an underwritten public offering of 6.8 million shares of its common stock. Sabra intends to grant the underwriters a 30-day option to purchase up to 1.02 million additional shares of its common stock.

Cirrus Logic, Inc. (NASDAQ: CRUS) 1.6% LOWER; Apple product cuts due to chip shortages.

Lordstown Motors Corp. (Nasdaq: RIDE) 1.6% HIGHER; announced today that its Board of Directors has elected Adam B. Kroll as Executive Vice President and Chief Financial Officer, effective October 25th, 2021. Mr. Kroll will replace Rebecca Roof, Interim Chief Financial Officer who will remain with the company in a transition role through December 31, 2021.

Apple (NASDAQ: AAPL) 1.5% LOWER; is likely to slash its projected iPhone 13 production targets for 2021 by as many as 10 million units because of prolonged chip shortages, according to Bloomberg, citing people with knowledge of the matter.

Broadcom Inc. (NASDAQ: AVGO) 1.4% LOWER; Apple product cuts due to chip shortages.

Qualcomm Incorporated (Nasdaq: QCOM) 1.4% HIGHER; announced after the close that its Board of Directors has approved a new $10.0 billion stock repurchase authorization, in addition to its July 18 stock repurchase program with a remaining $0.9 billion of repurchase authority.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Stifel, Keefe, Bruyette & Woods, UBS, JPMorgan, Morgan Stanley, Jefferies & Co, 13G, S1, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, FDA